Found: 20
Select item for more details and to access through your institution.
Raman microspectroscopy for label‐free diagnosis of amyloid light‐chain amyloidosis in various organs.
- Published in:
- Journal of Raman Spectroscopy, 2024, v. 55, n. 7, p. 753, doi. 10.1002/jrs.6665
- By:
- Publication type:
- Article
Correlation between high serum alkaline phosphatase levels and denosumab‐related hypocalcemia in patients with multiple myeloma.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 2, p. 355, doi. 10.1111/bjh.15837
- By:
- Publication type:
- Article
Class 1 HDAC and HDAC6 inhibition inversely regulates CD38 induction in myeloma cells via interferon‐α and ATRA.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 5, p. 969, doi. 10.1111/bjh.15673
- By:
- Publication type:
- Article
The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 929, doi. 10.3390/cancers12040929
- By:
- Publication type:
- Article
Intravenous busulfan-based conditioning with autologous stem cell transplantation for refractory B-cell lymphoma with central nervous system involvement.
- Published in:
- Journal of Medical Investigation, 2021, v. 68, n. 1/2, p. 196, doi. 10.2152/jmi.68.196
- By:
- Publication type:
- Article
P-023: Assessment of liver stiffness with shear wave elastography for hepatic AL amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S52, doi. 10.1016/S2152-2650(21)02157-1
- By:
- Publication type:
- Article
P-005: Novel strategy of elotuzumab and zoledronic acid with Th1-like γδT cells against myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S41, doi. 10.1016/S2152-2650(21)02139-X
- By:
- Publication type:
- Article
Synergistic targeting of Sp1 in myeloma cells with hyperthermia plus proteasome inhibitors.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e132, doi. 10.1016/j.clml.2019.09.219
- By:
- Publication type:
- Article
Targeting myeloma metabolisms regulated by HDAC1-IRF4 axis can be a novel therapeutic strategy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e105, doi. 10.1016/j.clml.2019.09.173
- By:
- Publication type:
- Article
Potential cytotoxic effect of hydroxypyruvate produced from d-serine by astroglial d-amino acid oxidase.
- Published in:
- Journal of Biochemistry, 2010, v. 148, n. 6, p. 743, doi. 10.1093/jb/mvq112
- By:
- Publication type:
- Article
The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2.
- Published in:
- Antioxidants, 2023, v. 12, n. 1, p. 133, doi. 10.3390/antiox12010133
- By:
- Publication type:
- Article
Ex vivo expansion and activation of Vγ9Vδ2 T cells by CELMoDs in combination with zoledronic acid.
- Published in:
- International Journal of Hematology, 2024, v. 119, n. 6, p. 626, doi. 10.1007/s12185-024-03763-7
- By:
- Publication type:
- Article
Acute suppression of translation by hyperthermia enhances anti-myeloma activity of carfilzomib.
- Published in:
- International Journal of Hematology, 2024, v. 119, n. 3, p. 291, doi. 10.1007/s12185-023-03706-8
- By:
- Publication type:
- Article
Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors.
- Published in:
- International Journal of Hematology, 2024, v. 119, n. 3, p. 303, doi. 10.1007/s12185-023-03705-9
- By:
- Publication type:
- Article
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 1, p. 88, doi. 10.1007/s12185-023-03601-2
- By:
- Publication type:
- Article
Involvement of oral bacteria and oral immunity as risk factors for chemotherapy-induced fever with neutropenia in patients with hematological cancer.
- Published in:
- International Journal of Hematology, 2020, v. 112, n. 6, p. 851, doi. 10.1007/s12185-020-02975-x
- By:
- Publication type:
- Article
TGF‐β‐activated kinase‐1 inhibitor LL‐Z1640‐2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF‐α and RANKL expression.
- Published in:
- Clinical & Translational Immunology, 2022, v. 11, n. 1, p. 1, doi. 10.1002/cti2.1371
- By:
- Publication type:
- Article
Cryptosporidiosis in a transplant recipient with severe intractable diarrhea: Detection of <italic>Cryptosporidium</italic> oocysts by intestinal biopsies.
- Published in:
- Transplant Infectious Disease, 2018, v. 20, n. 2, p. 1, doi. 10.1111/tid.12826
- By:
- Publication type:
- Article
Therapeutic efficacy of the resorcylic acid lactone LL‐Z1640‐2 for adult T‐cell leukaemia/lymphoma.
- Published in:
- EJHaem, 2023, v. 4, n. 3, p. 667, doi. 10.1002/jha2.758
- By:
- Publication type:
- Article
The importance of retaining physical functions to prevent skeletal‐related events in multiple myeloma patients with bone disease.
- Published in:
- EJHaem, 2022, v. 3, n. 2, p. 480, doi. 10.1002/jha2.402
- By:
- Publication type:
- Article